These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10673467)

  • 1. Mechanisms in COPD: differences from asthma.
    Barnes PJ
    Chest; 2000 Feb; 117(2 Suppl):10S-4S. PubMed ID: 10673467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
    COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma.
    Woodruff PG; Khashayar R; Lazarus SC; Janson S; Avila P; Boushey HA; Segal M; Fahy JV
    J Allergy Clin Immunol; 2001 Nov; 108(5):753-8. PubMed ID: 11692100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic phenotypes of airway disease.
    Pavord ID
    Ann Am Thorac Soc; 2013 Dec; 10 Suppl():S143-9. PubMed ID: 24313765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of inflammation mediators in bronchial asthma and chronic obstructive pulmonary disease].
    Chciałowski A; Targowski T
    Pol Merkur Lekarski; 1999 Jan; 6(31):1-4. PubMed ID: 10344143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Pattern of the Bronchial Mucosa in Patients with Asthma with Airway Hyperresponsiveness to Hypoosmotic Stimulus.
    Pirogov AB; Prikhod'ko AG; Perelman YM; Zinovyev SV; Afanasyeva EY; Kolosov VP
    Bull Exp Biol Med; 2016 Aug; 161(4):550-3. PubMed ID: 27591875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inflammatory response in asthma.
    Rachelefsky GS
    Am Fam Physician; 1992 Jan; 45(1):153-60. PubMed ID: 1728086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma as an inflammatory disease: implications for management.
    Dolen WK
    J Am Board Fam Pract; 1996; 9(3):182-90. PubMed ID: 8743231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils in asthma.
    Macdowell AL; Peters SP
    Curr Allergy Asthma Rep; 2007 Nov; 7(6):464-8. PubMed ID: 17986378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of inflammatory cell function by corticosteroids.
    Belvisi MG
    Proc Am Thorac Soc; 2004; 1(3):207-14. PubMed ID: 16113436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease.
    Postma DS; Kerstjens HA
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 3):S187-92. PubMed ID: 9817744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and airway reactivity in asthma.
    Pueringer RJ; Hunninghake GW
    Am J Med; 1992 Jun; 92(6A):32S-38S. PubMed ID: 1352426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharides promote a shift from Th2-derived airway eosinophilic inflammation to Th17-derived neutrophilic inflammation in an ovalbumin-sensitized murine asthma model.
    Zhao S; Jiang Y; Yang X; Guo D; Wang Y; Wang J; Wang R; Wang C
    J Asthma; 2017 Jun; 54(5):447-455. PubMed ID: 27589490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between peripheral blood leukocyte counts and respiratory symptoms, atopy, lung function, and airway responsiveness in adults.
    Lewis SA; Pavord ID; Stringer JR; Knox AJ; Weiss ST; Britton JR
    Chest; 2001 Jan; 119(1):105-14. PubMed ID: 11157591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice.
    Mizutani N; Nabe T; Yoshino S
    J Immunol; 2014 Feb; 192(4):1372-84. PubMed ID: 24446518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.
    Shaw DE; Berry MA; Hargadon B; McKenna S; Shelley MJ; Green RH; Brightling CE; Wardlaw AJ; Pavord ID
    Chest; 2007 Dec; 132(6):1871-5. PubMed ID: 17925424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap.
    Gao J; Zhou W; Chen B; Lin W; Wu S; Wu F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2703-2710. PubMed ID: 28979112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are chronic obstructive pulmonary disease (COPD) and asthma different diseases?
    Magnussen H; Richter K; Taube C
    Clin Exp Allergy; 1998 Nov; 28 Suppl 5():187-94; discussion 203-5. PubMed ID: 9988466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid reversibility in COPD is related to features of asthma.
    Chanez P; Vignola AM; O'Shaugnessy T; Enander I; Li D; Jeffery PK; Bousquet J
    Am J Respir Crit Care Med; 1997 May; 155(5):1529-34. PubMed ID: 9154853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges.
    Barrecheguren M; Esquinas C; Miravitlles M
    Curr Opin Pulm Med; 2015 Jan; 21(1):74-9. PubMed ID: 25405671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.